Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
about
Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.miRNAs As Emerging Regulators of Oligodendrocyte Development and DifferentiationIs It worth Considering Circulating microRNAs in Multiple Sclerosis?miRNAs: biological and clinical determinants in epilepsyBiomarkers of therapeutic response in multiple sclerosis: current statusmiRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agentsAnalysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms.Expression, regulation and function of microRNAs in multiple sclerosisMicroRNAs Correlate with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in a Chinese Population.Noninvasive micromarkersSmall and Long Regulatory RNAs in the Immune System and Immune DiseasesCirculating miRNAs in myasthenia gravis: miR-150-5p as a new potential biomarker.Circulating miR-150 in CSF is a novel candidate biomarker for multiple sclerosisNatalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b.Non-coding RNA: a new frontier in regulatory biology.Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy.Selected extracellular microRNA as potential biomarkers of multiple sclerosis activity--preliminary study.Assay reproducibility in clinical studies of plasma miRNAMicroRNA-572 expression in multiple sclerosis patients with different patterns of clinical progressionCirculating microRNAs are promising novel biomarkers for drug-resistant epilepsyNext-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis.Mitochondria-related miR-151a-5p reduces cellular ATP production by targeting CYTB in asthenozoospermiaDefining Plasma MicroRNAs Associated With Cognitive Impairment In HIV-Infected PatientsExpression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanismsDicer and microRNA expression in multiple sclerosis and response to interferon therapy.MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis.MicroRNA-142-5p contributes to Hashimoto's thyroiditis by targeting CLDN1MicroRNA expression changes during interferon-beta treatment in the peripheral blood of multiple sclerosis patientsCirculating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologiesComprehensive evaluation of serum microRNAs as biomarkers in multiple sclerosisA plasma microRNA signature as a biomarker for acquired aplastic anemia.LIN-28 balances longevity and germline stem cell number in Caenorhabditis elegans through let-7/AKT/DAF-16 axis.MicroRNAs and multiple sclerosis: from physiopathology toward therapy.The emerging role of circulating microRNAs as biomarkers in autoimmune diseases.Biomarker studies in multiple sclerosis: from proteins to noncoding RNAs.MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.MicroRNAs: Roles in Regulating Neuroinflammation.miRNA in multiple sclerosis: search for novel biomarkers.Body fluid biomarkers for multiple sclerosis--the long road to clinical application.Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
P2860
Q24289207-E1CBD571-BC54-44D0-AF01-D11A06DDDAAEQ26744461-8154F574-CE26-473A-9B8D-21BE742BE9E5Q26752505-3004F9B9-FFEE-4B71-940A-FD72E49BAC0FQ26777282-43B7C2D1-D4D0-4172-B029-B0CA60234915Q27012726-9103A853-E67B-460D-B9FB-0C8E44466126Q27023295-FDE9C896-5641-478C-909C-4E517250AFDCQ31134332-92C2090F-918A-49F0-90C7-36C47FD1C343Q33754662-B6E27E04-2D98-49DD-B4F6-25F02B2A7FC8Q33763366-03BA3B88-E05E-4437-B890-7ECB4C817134Q34111606-C375EC7E-52DB-405A-808D-8817957AD912Q34368789-83DD33A1-907F-45FE-AEF9-1DDA0F5F2F4BQ34393904-C08BAFAB-BC94-485B-B62A-21C1A4E90C01Q34524908-DDA5BE14-405C-4CF0-B326-B2BD0130BCF2Q34994463-C29A4578-D3D7-4C78-9E37-B3B3F2D78EB8Q35218913-6A1FC022-04EE-4393-B807-985BCB0F1A6FQ35232595-DF995442-CA05-4775-BD5C-19AF7DE138BBQ35244158-E1CF9E76-0792-481F-B28A-CECF8D194488Q35325816-62C195C3-5BE5-4468-AF9D-F37E9ADAF45FQ35599410-250697A4-D1DC-4EDF-82B0-38BC96307BEFQ35617456-54AF872A-FCF2-4854-A030-B1EB6B7233EAQ35828632-44BEFA16-16DF-4DBB-A617-473888F92C88Q36340135-0888C334-E474-44E2-B551-1E50A081B01EQ36594081-FC421277-8F5A-45AB-8E9E-AC5942793F82Q36601006-C8ABE4D2-7545-48E7-8ADF-31A63B35AE27Q36655150-9A9C2FA9-BA0A-4633-A8B0-389DF9AB39FCQ36967729-5039D780-8A81-448C-8D8C-E6F0826C5101Q36982325-4E2BC312-5DEE-4B18-A915-2D2C49C0C4BEQ37139127-CE682418-B2A7-48D5-B911-A145B6289D23Q37158033-0DF6B450-E08F-4C84-83A0-8761DA52A193Q37201031-36A37020-4875-43EC-9F33-6140A89F258AQ37555805-DEA41F4C-8A64-4FE6-AC9C-31CE09ACDA87Q37592007-62F81D01-A786-4D19-AEB9-7B352EBA2AA4Q38140046-3DA8E038-68A6-4194-9418-EB45AC6A5AF7Q38222306-B870F284-7A81-4E85-84E6-2B3ECE58CD21Q38234717-D3D65FB3-AD8C-4A0A-AF3F-76D877B3C2FDQ38272668-20D2766B-E0AB-4867-A4B2-557531AA5856Q38287691-C7C84A18-5E36-4C65-9C41-CFD51B2DB148Q38447020-B8B5CD0A-68D0-4A03-B2D3-93E8C3FE4DACQ38590773-04A5667B-12EC-4A66-A28C-3D0F232B8FC5Q38610689-A100DBD4-32E0-4206-ABE6-E0EC246BB0C6
P2860
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@ast
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@en
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@nl
type
label
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@ast
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@en
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@nl
prefLabel
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@ast
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@en
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis
@en
P2093
Alexander Musallam
Bonny Patel
Brian Healy
Francisco Quintana
Hillary Hei
Mohammad Shuja Hussain
Parham Nejad
Pia Kivisakk
Roopali Gandhi
Taha Gholipour
P2860
P304
P3181
P356
10.1002/ANA.23880
P407
P577
2013-06-01T00:00:00Z